Publications 2025

Agostini V, Henschler R, Lunde THF, Kristoffersen EK, Hetland G, Danilova E, Martin A, Prudent M, Grazzini G, De Franceschi L, Walicka I, Wagner J, Omert L (2025)
A validation study of the in vitro performance of hypoxic red blood cells for transfusion across centers in Europe
(in press)
DOI 10.1111/trf.18408, PubMed 41163483

Hauge T, Franco-Lie I, Hetland G, Waage A, Drewes AM, Fagerhol MK (2025)
LeLISA: A New Lectin-Based Immunoassay for Evaluation of Mucinous and Serous Content in Pancreatic Cystic Neoplasms
70 (10), 3412-3418
DOI 10.1007/s10620-025-09188-4, PubMed 40591230

Hauge T, Franco-Lie I, Hetland G, Waage A, Drewes AM, Fagerhol MK (2025)
LeLISA: A New Lectin‑Based Immunoassay for Evaluation of Mucinous and Serous Content in Pancreatic Cystic Neoplasms
(in press)
DOI 10.1007/s10620-025-09448-3, PubMed 41091285

Mahmood F, Hetland G, Mirlashari MR, Nissen-Meyer LSH (2025)
IgE sensitization profiles to food, inhalant and insect venom in Norwegian blood donors and their impact on blood transfusions
101 (1), e13425
DOI 10.1111/sji.13425, PubMed 39648460

Publications 2024

Danilova E, Ezligini F, Stöckel C, Asakawa M, Hetland G (2024)
An evaluation of diethylhexyl phthalate free top & bottom in-line blood collection set with a new soft housing filter
35 (1), 82-90
DOI 10.1111/tme.13091, PubMed 39243178

Hetland G, Fagerhol MK, Mirlashari MR, Nissen-Meyer LSH, Croci S, Lonati PA, Bonacini M, Salvarani C, Marvisi C, Bodio C, Muratore F, Borghi MO, Meroni PL (2024)
Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy
12 (4)
DOI 10.3390/biomedicines12040766, PubMed 38672123

Publications 2023

Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
98 (1), e13274
DOI 10.1111/sji.13274, PubMed 37676118

Mahmood F, Nissen-Meyer LSH, Hetland G, Nentwich I (2023)
Assessing IgE sensitization profiles to birch and timothy grass pollen allergens in birch pollen allergic blood donors using an oligoplex specific IgE assay
83 (7), 444-447
DOI 10.1080/00365513.2023.2255972, PubMed 37737679

Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Hetland G (2023)
Effects of storage on quality and function of acid-treated platelets with reduced HLA Class I surface expression
33 (4), 329-336
DOI 10.1111/tme.12983, PubMed 37356816

Reikvam H, Hetland G, Ezligini F, Dorsch K, Omert L, Dunham A, Almeland SK (2023)
Safety of hypoxic red blood cell administration in patients with transfusion-dependent hematological malignancies: An interim analysis
62 (5), 103755
DOI 10.1016/j.transci.2023.103755, PubMed 37423867

Publications 2022

Hetland G, Fagerhol MK, Dimova-Svetoslavova VP, Mirlashari MR, Nguyen NT, Lind A, Kolset SO, Søraas AVL, Nissen-Meyer LSH (2022)
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors
82 (6), 481-485
DOI 10.1080/00365513.2022.2123387, PubMed 36151851

Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
10 (8)
DOI 10.3390/vaccines10081267, PubMed 36016155

Meroni PL, Croci S, Lonati PA, Pregnolato F, Spaggiari L, Besutti G, Bonacini M, Ferrigno I, Rossi A, Hetland G, Hollan I, Cugno M, Tedesco F, Borghi MO, Salvarani C (2022)
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients
22 (1), 103232
DOI 10.1016/j.autrev.2022.103232, PubMed 36414219

Nissen-Meyer LSH, Ezligini F, Bergerud UE, Holtan A, Akkök ÇA, Danilova E, Hetland G (2022)
[Blood and emergency preparedness]
142 (11)
DOI 10.4045/tidsskr.22.0494, PubMed 35997179

Publications 2021

Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Naper C, Tjønnfjord GE, Njerve IU, Ezligini F, Landmark BF, Meinke S, Sandgren P, Höglund P, Hetland G (2021)
HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients
61 (4), 1222-1234
DOI 10.1111/trf.16282, PubMed 33580979

Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Stensland ME, Singh SK, Nyman TA, Hetland G (2021)
Proteomic study of apheresis platelets made HLA class I deficient for transfusion of refractory patients
15 (6), e2100022
DOI 10.1002/prca.202100022, PubMed 34510746

Publications 2020

Fagerhol MK, Johnson E, Tangen JM, Hollan I, Mirlashari MR, Nissen-Meyer LSH, Hetland G (2020)
NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study
91 (5), e12870
DOI 10.1111/sji.12870, PubMed 32034957

Hetland G, Johnson E, Bernardshaw SV, Grinde B (2020)
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation?
93 (1), e12937
DOI 10.1111/sji.12937, PubMed 32657436

Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E (2020)
Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies
12 (5)
DOI 10.3390/nu12051339, PubMed 32397163

Publications 2019

Johnson E, Therkelsen SP, Nentwich I, Nissen-Meyer LSH, Hetland G (2019)
IgE-sensitization to food and inhalant allergens in IBD patients compared with normal blood donors at Oslo University Hospital, Norway
54 (9), 1107-1110
DOI 10.1080/00365521.2019.1663445, PubMed 31524013

Mahmood F, Hetland G, Nentwich I, Mirlashari MR, Ghiasvand R, Nissen-Meyer LSH (2019)
Agaricus blazei-Based Mushroom Extract Supplementation to Birch Allergic Blood Donors: A Randomized Clinical Trial
11 (10)
DOI 10.3390/nu11102339, PubMed 31581605

Publications 2017

Tangen JM, Holien T, Mirlashari MR, Misund K, Hetland G (2017)
Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan (TM)
Biomed Res. Int., 2017, 2059825
DOI 10.1155/2017/2059825

Publications 2016

Hetland G, Eide DM, Tangen JM, Haugen MH, Mirlashari MR, Paulsen JE (2016)
The Agaricus blazei-Based Mushroom Extract, Andosan™, Protects against Intestinal Tumorigenesis in the A/J Min/+ Mouse
11 (12), e0167754
DOI 10.1371/journal.pone.0167754, PubMed 28002446

Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study
11 (3), e0150191
DOI 10.1371/journal.pone.0150191, PubMed 26933886

Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSanTM, on Symptoms, Fatigue and Quality of Life in Patients with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study
11 (7), e0159288
DOI 10.1371/journal.pone.0159288, PubMed 27415795

Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan^™ , in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single-Blinded Placebo-Controlled Study
84 (6), 323-331
DOI 10.1111/sji.12476, PubMed 27588816

Publications 2015

Berven L, Karppinen P, Hetland G, Samuelsen ABC (2015)
The Polar High Molecular Weight Fraction of the Agaricus blazei Murill Extract, AndoSan (TM), Reduces the Activity of the Tumor-Associated Protease, Legumain, in RAW 264.7 Cells
J. Med. Food, 18 (4), 429-438
DOI 10.1089/jmf.2014.0018

Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM, Wang J, Tjønnfjord GE, Hetland G (2015)
Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study
2015, 718539
DOI 10.1155/2015/718539, PubMed 25664323

Publications 2012

Biedron R, Tangen JM, Maresz K, Hetland G (2012)
Agaricus blazei Murill - immunomodulatory properties and health benefits
Funct. Foods Health Dis., 2 (11), 428-447
DOI 10.31989/ffhd.v2i11.72

Johnson E, Førland DT, Hetland G, Sætre L, Olstad OK, Lyberg T (2012)
Effect of AndoSan™ on expression of adhesion molecules and production of reactive oxygen species in human monocytes and granulocytes in vivo
47 (8-9), 984-92
DOI 10.3109/00365521.2012.660544, PubMed 22564240

Publications 2011

Førland DT, Johnson E, Saetre L, Lyberg T, Lygren I, Hetland G (2011)
Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease
73 (1), 66-75
DOI 10.1111/j.1365-3083.2010.02477.x, PubMed 21129005

Hetland G, Johnson E, Lyberg T, Kvalheim G (2011)
The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation
2011, 157015
DOI 10.1155/2011/157015, PubMed 21912538

Publications 2010

Bertelsen RJ, Instanes C, Granum B, Carlsen KCL, Hetland G, Carlsen KH, Mowinckel P, Lovik M (2010)
Gender differences in indoor allergen exposure and association with current rhinitis
Clin. Exp. Allergy, 40 (9), 1388-1397
DOI 10.1111/j.1365-2222.2010.03543.x

Publications 2009

Ellertsen LK, Hetland G (2009)
An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy
7, 6
DOI 10.1186/1476-7961-7-6, PubMed 19416507

Ellertsen LK, Storla DG, Diep LM, Brokstad KA, Wiker HG, Hetland G (2009)
Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy
BMC Infect. Dis., 9, 100
DOI 10.1186/1471-2334-9-100

Førland DT, Johnson E, Tryggestad AM, Lyberg T, Hetland G (2009)
An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro
49 (3), 245-50
DOI 10.1016/j.cyto.2009.09.002, PubMed 20036142

Johnson E, Førland DT, Saetre L, Bernardshaw SV, Lyberg T, Hetland G (2009)
Effect of an extract based on the medicinal mushroom Agaricus blazei murill on release of cytokines, chemokines and leukocyte growth factors in human blood ex vivo and in vivo
69 (3), 242-50
DOI 10.1111/j.1365-3083.2008.02218.x, PubMed 19281536

Publications 2008

Ellertsen LK, Hetland G, Lovik M (2008)
Specific IgE to respiratory allergens and IgG antibodies to Toxoplasma gondii and Streptococcus pneumoniae in norwegian military recruits
Scand. J. Immunol., 67 (5), 496-500
DOI 10.1111/j.1365-3083.2008.02090.x

Herseth JI, Refsnes M, Lag M, Hetland G, Schwarze PE (2008)
IL-1 beta as a determinant in silica-induced cytokine responses in mono cyte-endothelial cell co-cultures
Hum. Exp. Toxicol., 27 (5), 387-399
DOI 10.1177/0960327108094610

Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AM, Grinde B (2008)
Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer
68 (4), 363-70
DOI 10.1111/j.1365-3083.2008.02156.x, PubMed 18782264

Rydjord B, Marton JH, Stromsnes H, Granum B, Bolle R, Nystad W, Hetland G (2008)
Mould-specific immunoglobulin antibodies quantified by flow cytometry reflect mould exposure in Norwegian children
Clin. Exp. Allergy, 38 (3), 430-437
DOI 10.1111/j.1365-2222.2007.02905.x

Publications 2007

Bernardshaw S, Lyberg T, Hetland G, Johnson E (2007)
Effect of an extract of the mushroom Agaricus blazei Murill on expression of adhesion molecules and production of reactive oxygen species in monocytes and granulocytes in human whole blood ex vivo
115 (6), 719-25
DOI 10.1111/j.1600-0463.2007.apm_619.x, PubMed 17550380

Publications 2006

Bernardshaw S, Hetland G, Grinde B, Johnson E (2006)
An extract of the mushroom Agaricus blazei Murill protects against lethal septicemia in a mouse model of fecal peritonitis
25 (4), 420-5
DOI 10.1097/01.shk.0000209526.58614.92, PubMed 16670646

Ellertsen LK, Hetland G, Johnson E, Grinde B (2006)
Effect of a medicinal extract from Agaricus blazei Murill on gene expression in a human monocyte cell line as examined by microarrays and immuno assays
Int. Immunopharmacol., 6 (2), 133-143
DOI 10.1016/j.intimp.2005.07.007

Instanes C, Ward MDW, Hetland G (2006)
The fungal biopesticide Metarhizium anisopliae has an adjuvant effect on the allergic response to ovalbumin in mice
Toxicol. Lett., 161 (3), 219-225
DOI 10.1016/j.toxlet.2005.09.006

Publications 2005

Bernardshaw S, Hetland G, Ellertsen LK, Tryggestad AM, Johnson E (2005)
An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro
29 (4-6), 147-53
DOI 10.1007/s10753-006-9010-2, PubMed 17091395

Bernardshaw S, Johnson E, Hetland G (2005)
An extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice
62 (4), 393-8
DOI 10.1111/j.1365-3083.2005.01667.x, PubMed 16253127

Ellertsen LK, Wiker HG, Egeberg NT, Hetland G (2005)
Allergic sensitisation in tuberculosis and leprosy patients
Int. Arch. Allergy Immunol., 138 (3), 217-224
DOI 10.1159/000088722

Instanes C, Hetland G, Berntsen S, Løvik M, Nafstad P (2005)
Allergens and endotoxin in settled dust from day-care centers and schools in Oslo, Norway
15 (5), 356-62
DOI 10.1111/j.1600-0668.2005.00381.x, PubMed 16108908

Rydjord B, Hetland G, Wiker HG (2005)
Immunoglobulin G antibodies against environmental moulds in a Norwegian healthy population shows a bimodal distribution for Aspergillus versicolor
Scand. J. Immunol., 62 (3), 281-288
DOI 10.1111/j.1365-3083.2005.01672.x

Publications 2004

Bernardshaw S, Johnson E, Hetland G (2004)
Extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice
IMMUNOLOGY 2004: GENOMIC ISSUES, IMMUNE SYSTEM ACTIVATION AND ALLERGY, 473-477

Instanes C, Hetland G (2004)
Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy
Toxicology, 204 (1), 13-21
DOI 10.1016/j.tox.2004.05.011

Instanes C, Ormstad H, Rydjord B, Wiker HG, Hetland G (2004)
Mould extracts increase the allergic response to ovalbumin in mice
Clin. Exp. Allergy, 34 (10), 1634-1641
DOI 10.1111/j.1365-2222.2004.02076.x

Publications 2003

Berge V, Langeggen H, Johnson E, Hetland G (2003)
Comparison of BTA Stat and enzyme immuno assay bladder tumor antigen in urine from patients with pathology in the urinary tract
In Scandinavian journal of urology and nephrology, Supplementum, Taylor & Francis, Oxford, 37(2003)suppl 214, s.48-9 abstract P14
BIBSYS 041732154

Langeggen H, Namork E, Johnson E, Hetland G (2003)
HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro
36 (1-2), 55-61
DOI 10.1016/S0928-8244(03)00033-6, PubMed 12727366

Publications 2002

Hetland G, Sandven P (2002)
beta-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures
33 (1), 41-5
DOI 10.1111/j.1574-695X.2002.tb00570.x, PubMed 11985967

Langeggen H, Berge KE, Johnson E, Hetland G (2002)
Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro
26 (3), 103-10
DOI 10.1023/a:1015585530204, PubMed 12083416

Publications 2001

Hetland G, Granum B, Groeng EC, Lovik M (2001)
Leptin does not influence the IgE response to ovalbumin in mice
Clin. Immunol., 101 (1), 8-11
DOI 10.1006/clim.2001.5087

Langeggen H, Berge KE, Macor P, Fischetti F, Tedesco F, Hetland G, Berg K, Johnson E (2001)
Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro
109 (1), 73-8
DOI 10.1111/j.1600-0463.2001.tb00016.x, PubMed 11297196

Langeggen H, Johnson E, Hetland G (2001)
Effects of C5a and FMLP on interleukin-8 production and proliferation of human umbilical vein endothelial cells
25 (2), 83-9
DOI 10.1023/a:1007162320882, PubMed 11321363

Publications 2000

Hetland G, Namork E, Schwarze PE, Aase A (2000)
Mechanism for uptake of silica particles by monocytic U937 cells
Hum. Exp. Toxicol., 19 (7), 412-419
DOI 10.1191/096032700678816106

Hetland G, Ohno N, Aaberge IS, Lovik M (2000)
Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice
FEMS Immunol. Med. Microbiol., 27 (2), 111-116
DOI 10.1111/j.1574-695X.2000.tb01420.x

Hetland G, Samuelsen AB, Lovik M, Paulsen BS, Aaberge IS, Groeng EC, Michaelsen TE (2000)
Protective effect of Plantago major L. pectin polysaccharide against systemic Streptococcus pneumoniae infection in mice
Scand. J. Immunol., 52 (4), 348-355
DOI 10.1046/j.1365-3083.2000.00793.x

Johnson E, Langeggen H, Hetland G (2000)
Concentrations of leucocyte-associated chemotaxin C5a correlate with the mobilisation of polymorphonuclear leucocytes during operations for rectal cancer
166 (2), 159-64
DOI 10.1080/110241500750009528, PubMed 10724495

Johnson E, Langeggen H, Hetland G (2000)
Concentrations of leucocyte-associated chemotaxin C5a correlate with the mobilisation of polymorphonuclear leucocytes during operations for rectal cancer
Eur. J. Surg., 166 (2), 159-164

Ormstad H, Groeng EC, Lovik M, Hetland G (2000)
The fungal cell wall component beta-1,3-glucan has an adjuvant effect on the allergic response to ovalbumin in mice
J. TOXICOL. ENV. HEALTH PT A, 61 (1), 55-67
DOI 10.1080/00984100050116780

Publications 1998

Baksaas ST, Videm V, Mollnes TE, Tølløfsrud S, Hetland G, Pedersen T, Svennevig JL (1998)
Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
13 (6), 429-36
DOI 10.1177/026765919801300606, PubMed 9881390

Hetland G, Lovik M, Wiker HG (1998)
Protective effect of beta-glucan against Mycobacterium bovis, BCG infection in BALB/c mice
Scand. J. Immunol., 47 (6), 548-553

Hetland G, Løvik M, Wiker HG (1998)
Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice
47 (6), 548-53
DOI 10.1046/j.1365-3083.1998.00350.x, PubMed 9652822

Hetland G, Mollnes TE, Bergh K, Høgåsen K, Bergerud UE, Solheim BG (1998)
Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4
38 (1), 16-23
DOI 10.1046/j.1537-2995.1998.38198141493.x, PubMed 9482389

Hetland G, Solheim BG (1998)
Quality of platelet concentrates Reply
Transfusion, 38 (8), 799-800

Hetland G, Talgö GJ, Fagerhol MK (1998)
Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro
51 (3), 143-8
DOI 10.1136/mp.51.3.143, PubMed 9850337

Hetland G, Wiker HG, Høgåsen K, Hamasur B, Svenson SB, Harboe M (1998)
Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis
5 (2), 211-8
DOI 10.1128/CDLI.5.2.211-218.1998, PubMed 9521145

Publications 1997

Hetland G (1997)
Cytotoxic effect of dibutyryl cAMP, phorbol-12-myristate-13-acetate and lipopolysaccharide, but not interferon-gamma, on promonocytic cell lines in vitro
8 (6), 618-22
DOI 10.1097/00001813-199707000-00010, PubMed 9300577

Hetland G (1997)
Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo
Society of Thoracic Surgeons, [New York], Bl. [1076]-1080
BIBSYS 981784690

Hetland G (1997)
Effect of leukocyte-filtration and storage of platelet concentrates on complement activation and production of chemotaxins C5a, IL-8, TNFα and LTB4
[Karger], [Basel], Bl. 95.
BIBSYS 982303211

Hetland G, Moen O, Bergh K, Högäsen K, Hack CE, Mollnes TE, Fosse E (1997)
Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo
63 (4), 1076-80
DOI 10.1016/s0003-4975(96)01255-6, PubMed 9124908

Publications 1996

Hetland G, Hugli TE (1996)
Cytotoxic effect of radiolabeled C5a on U937 cells in vitro
110 (1-2), 97-103
DOI 10.1016/s0304-3835(96)04467-9, PubMed 9018087

Publications 1995

Hetland G, Guinn K, Hugli TE (1995)
Of formyl peptide-toxin conjugates on myeloid cancer cell lines in vitro
Int. J. Immunother., 11 (3), 85-93

Publications 1994

Hetland G, Wiker HG (1994)
Antigen 85C on Mycobacterium bovis, BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products
82 (3), 445-9
PubMed 7959881

HETLAND G, WIKER HG (1994)
ANTIGEN 85C ON MYCOBACTERIUM-BOVIS, BCG AND MYCOBACTERIUM-TUBERCULOSIS PROMOTES MONOCYTE-CR3-MEDIATED UPTAKE OF MICROBEADS COATED WITH MYCOBACTERIAL PRODUCTS
Immunology, 82 (3), 445-449

Publications 1993

Hetland G, Mollnes TE, Garred P (1993)
The B chain, but not the A chain, of Ricinus communis activates human complement
75 (1), 59-63
DOI 10.1016/0304-3835(93)90208-q, PubMed 8287382

Publications 1992

BERGE V, JOHNSON E, HOGASEN K, HETLAND G (1992)
HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS SYNTHESIZE S-PROTEIN (VITRONECTIN) INVITRO
Scand. J. Immunol., 36 (1), 119-123
DOI 10.1111/j.1365-3083.1992.tb02947.x

HETLAND G, BERNTZEN HB, FAGERHOL MK (1992)
LEVELS OF CALPROTECTIN (LEUKOCYTE L1 PROTEIN) DURING APHERESIS
Scand. J. Clin. Lab. Invest., 52 (6), 479-482
DOI 10.3109/00365519209090124

HETLAND G, HOLME I, STROMME JH (1992)
CO-VARIATION OF ALANINE AMINOTRANSFERASE LEVELS WITH RELATIVE WEIGHT IN BLOOD-DONORS
Scand. J. Clin. Lab. Invest., 52 (1), 51-55
DOI 10.3109/00365519209085440

HETLAND G, MOLLNES TE, LARSEN J, GARRED P (1992)
BIOCOMPATIBILITY OF WHITE CELL FILTERS AS EVALUATED BY COMPLEMENT ACTIVATION
Transfusion, 32 (6), 557-561
DOI 10.1046/j.1537-2995.1992.32692367201.x

Publications 1991

Hetland G, Garred P, Mollnes TE, Størvold G (1991)
The use of flow cytometry to detect the biosynthesis of complement components
140 (2), 167-71
DOI 10.1016/0022-1759(91)90367-o, PubMed 2066563

HETLAND G, MOLLNES TE, GARRED P (1991)
ACTIVATION OF COMPLEMENT DURING APHERESIS
Clin. Exp. Immunol., 84 (3), 535-538

JOHNSON E, HETLAND G (1991)
HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS SYNTHESIZE FUNCTIONAL C3, C5, C6, C8 AND C9 INVITRO
Scand. J. Immunol., 33 (6), 667-671
DOI 10.1111/j.1365-3083.1991.tb02539.x

Larsen J, Hetland G, Skaug K, Maeland A (1991)
[Viral hepatitis and blood transfusion]
111 (7), 825-8
PubMed 1850559

Larsen J, Skaug K, Maeland A, Hetland G, Stoervold G (1991)
Infective, chronic carriers of hepatitis C virus among blood donors with no history of clinical hepatitis
1 (1), 13-6
DOI 10.1111/j.1365-3148.1991.tb00003.x, PubMed 9259821

Publications 1990

Garred P, Hetland G, Mollnes TE, Stoervold G (1990)
Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts
32 (5), 555-60
DOI 10.1111/j.1365-3083.1990.tb03196.x, PubMed 2270435

HETLAND G, GARRED P, PETTERSEN HB, MOLLNES TE, JOHNSON E (1990)
S-PROTEIN BINDS TO SERUM-TREATED AGAROSE BEADS INDEPENDENTLY OF COMPLEMENT ACTIVATION AND THE FORMATION OF THE TERMINAL COMPLEMENT COMPLEX ON THE BEADS
Clin. Exp. Immunol., 79 (3), 459-462

Hetland G, Skaug K, Larsen J, Maland A, Strømme JH, Størvold G (1990)
Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels
30 (9), 776-9
DOI 10.1046/j.1537-2995.1990.30991048780.x, PubMed 2173175

LARSEN J, HETLAND G, SKAUG K (1990)
POSTTRANSFUSION HEPATITIS-B TRANSMITTED BY BLOOD FROM A HEPATITIS-B SURFACE ANTIGEN-NEGATIVE HEPATITIS-B VIRUS CARRIER
Transfusion, 30 (5), 431-432
DOI 10.1046/j.1537-2995.1990.30590296376.x

PETTERSEN HB, JOHNSON E, GARRED P, HETLAND G, OSEN SS, MOLLNES TE (1990)
QUANTIFICATION OF NON-ACTIVATED (NATIVE) COMPLEMENT COMPONENT C9 SYNTHESIZED BY ALVEOLAR MACROPHAGES FROM PATIENTS WITH SARCOIDOSIS
Scand. J. Immunol., 31 (5), 657-663
DOI 10.1111/j.1365-3083.1990.tb02816.x

PETTERSEN HB, JOHNSON E, MOLLNES TE, GARRED P, HETLAND G, OSEN SS (1990)
SYNTHESIS OF COMPLEMENT BY ALVEOLAR MACROPHAGES FROM PATIENTS WITH SARCOIDOSIS
Scand. J. Immunol., 31 (1), 15-23
DOI 10.1111/j.1365-3083.1990.tb02738.x

Publications 1989

HETLAND G, PETTERSEN HB, MOLLNES TE, JOHNSON E (1989)
S-PROTEIN IS SYNTHESIZED BY HUMAN-MONOCYTES AND MACROPHAGES INVITRO
Scand. J. Immunol., 29 (1), 15-21
DOI 10.1111/j.1365-3083.1989.tb01094.x

Publications 1988

HETLAND G, BUNGUM L (1988)
HUMAN PERITONEAL-MACROPHAGES - PRODUCTION INVITRO OF THE ACTIVE TERMINAL COMPLEMENT COMPONENTS C5 TO C9 AND A FUNCTIONAL ALTERNATIVE PATHWAY OF COMPLEMENT
APMIS, 96 (1), 89-92
DOI 10.1111/j.1699-0463.1988.tb05273.x

JOHNSON E, HETLAND G (1988)
A SENSITIVE METHOD TO DETECT SYNTHESIS OF THE FUNCTIONAL CLASSICAL, ALTERNATIVE AND TERMINAL PATHWAY OF COMPLEMENT BY CELLS CULTURED INVITRO
Scand. J. Clin. Lab. Invest., 48 (3), 223-231
DOI 10.3109/00365518809167488

JOHNSON E, HETLAND G (1988)
MONONUCLEAR PHAGOCYTES HAVE THE POTENTIAL TO SYNTHESIZE THE COMPLETE FUNCTIONAL COMPLEMENT-SYSTEM
Scand. J. Immunol., 27 (5), 489-493
DOI 10.1111/j.1365-3083.1988.tb02375.x

Publications 1987

Hetland G (1987)
Biosynthesis of complement in mononuclear phagocytes
[G. Hetland], Tromsø, 1 b. (fl.pag.)
BIBSYS 883027607

HETLAND G, ESKELAND T (1987)
MOUSE PERITONEAL-MACROPHAGES CULTURED SERUM-FREE DEPOSIT COMPLEMENT ON IGM-COATED SHEEP ERYTHROCYTES INVITRO
ACTA PATH MICRO IM C, 95 (1), 15-20

HETLAND G, JOHNSON E, ESKELAND T (1987)
FORMATION OF THE MEMBRANE ATTACK COMPLEX OF COMPLEMENT (MAC) ON ERYTHROCYTES FROM MONOCYTE-PRODUCED TERMINAL COMPLEMENT COMPONENTS
Scand. J. Immunol., 25 (6), 571-577
DOI 10.1111/j.1365-3083.1987.tb01083.x

HETLAND G, JOHNSON E, ROYSET P, ESKELAND T (1987)
HUMAN ALVEOLAR MACROPHAGES AND MONOCYTES GENERATE THE FUNCTIONAL CLASSICAL PATHWAY OF COMPLEMENT INVITRO
ACTA PATH MICRO IM C, 95 (3), 117-122

PETTERSEN HB, JOHNSON E, HETLAND G (1987)
HUMAN ALVEOLAR MACROPHAGES SYNTHESIZE ACTIVE COMPLEMENT COMPONENT-C6, COMPONENT-C7, AND COMPONENT-C8 INVITRO
Scand. J. Immunol., 25 (6), 567-570
DOI 10.1111/j.1365-3083.1987.tb01082.x

Publications 1986

HETLAND G, ESKELAND T (1986)
FORMATION OF THE FUNCTIONAL ALTERNATIVE PATHWAY OF COMPLEMENT BY HUMAN-MONOCYTES INVITRO AS DEMONSTRATED BY PHAGOCYTOSIS OF AGAROSE BEADS
Scand. J. Immunol., 23 (3), 301-308
DOI 10.1111/j.1365-3083.1986.tb01971.x

HETLAND G, JOHNSON E, FALK RJ, ESKELAND T (1986)
SYNTHESIS OF COMPLEMENT COMPONENTS C5, C6, C7, C8 AND C9 INVITRO BY HUMAN-MONOCYTES AND ASSEMBLY OF THE TERMINAL COMPLEMENT COMPLEX
Scand. J. Immunol., 24 (4), 421-428
DOI 10.1111/j.1365-3083.1986.tb02130.x

HETLAND G, JOHNSON E, AASEBO U (1986)
HUMAN ALVEOLAR MACROPHAGES SYNTHESIZE THE FUNCTIONAL ALTERNATIVE PATHWAY OF COMPLEMENT AND ACTIVE C5 AND C9 INVITRO
Scand. J. Immunol., 24 (5), 603-608
DOI 10.1111/j.1365-3083.1986.tb02176.x

JOHNSON E, LARSEN T, HETLAND G (1986)
PHAGOCYTOSIS OF AGAROSE BEADS BY RECEPTORS FOR C3B (CR-1) AND IC3B (CR3) ON HUMAN ALVEOLAR MACROPHAGES CULTURED ON FIBRONECTIN INVITRO - A SCANNING ELECTRON-MICROSCOPIC STUDY
Scand. J. Immunol., 24 (6), 653-660
DOI 10.1111/j.1365-3083.1986.tb02184.x